WHO ICTRP trial
Efficacy of Sofosbuvir as treatment for Yellow Fever
RBR-93dp9n · Registro Brasileiro de Ensaios Clinicos (ReBEC) · Recruiting
Key facts
| Trial ID | RBR-93dp9n |
|---|---|
| Public title | Efficacy of Sofosbuvir as treatment for Yellow Fever |
| Scientific title | Efficacy of Sofosbuvir as treatment for Yellow Fever: randomized clinical trial (SOFFA trial) - SOFFA |
| Primary sponsor | Fundação Faculdade de Medicina |
| Secondary sponsors | Fundação Faculdade de Medicina |
| Registry | Registro Brasileiro de Ensaios Clinicos (ReBEC) |
| Recruitment status | Recruiting |
| Study type | Intervention |
| Countries | Brazil |
| Conditions | Yellow fever;C02.081.980 |
| Interventions | Regimen 1 - Intervention: 45 patients will receive Sofosbuvir 400 mg once a day per 10 days + clinical intervention at attending physician´s discretion Regimen 2 - Control: 45 patients will receive clinical intervention at attending… |
| Registration date | May 14, 2018 |
| Registry page | ensaiosclinicos.gov.br |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: